Literature DB >> 438845

A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis.

I V Allen, S R McKeown.   

Abstract

In a combined histological, biochemical and histochemical study of the macroscopically normal white matter in multipe sclerosis 72% of samples were histologically abnormal. The significance of this fact in the interpretation of previous biochemical studies and in the design of future studies is discussed. The present study showed a significant elevation of the lysosomal enzyme beta-glucosaminidase in the microscopically normal white matter in MS as compared with controls. Studies on lysosomes separated from microscopically normal or mild to moderately gliosed white matter in multiple sclerosis showed an increase in lysosomal fragility. Histochemical study of the microscopically normal white matter in multiple sclerosis revealed an increase in the number of acid phosphate-containing cells as compared with normal and neurological control material. The significance of these findings is discussed and it is suggested that irrespective of the primary or secondary nature of these abnormalities, the white matter may be rendered more susceptible to the pathogenetic process in this disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 438845     DOI: 10.1016/0022-510x(79)90142-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  68 in total

1.  Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging.

Authors:  A C Guo; V L Jewells; J M Provenzale
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Diffusion tensor imaging applications in multiple sclerosis patients using 3T magnetic resonance: a preliminary study.

Authors:  Lorenzo Testaverde; Laura Caporali; Eugenio Venditti; Giovanni Grillea; Claudio Colonnese
Journal:  Eur Radiol       Date:  2011-12-09       Impact factor: 5.315

3.  Measurement of volumetric lesion load in multiple sclerosis: moving from normal- to dirty-appearing white matter.

Authors:  Sandy Cheng-Yu Chen; Hsiao-Wen Chung; Michelle Liou
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

4.  Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis.

Authors:  Bertrand Audoin; My Van Au Duong; Jean-Philippe Ranjeva; Danielle Ibarrola; Irina Malikova; Sylviane Confort-Gouny; Elisabeth Soulier; Patrick Viout; André Ali-Chérif; Jean Pelletier; Patrick J Cozzone
Journal:  Hum Brain Mapp       Date:  2005-03       Impact factor: 5.038

5.  Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.

Authors:  M Inglese; G Madelin; N Oesingmann; J S Babb; W Wu; B Stoeckel; J Herbert; G Johnson
Journal:  Brain       Date:  2010-01-27       Impact factor: 13.501

6.  Prospects for the treatment of multiple sclerosis.

Authors: 
Journal:  J R Soc Med       Date:  1991-06       Impact factor: 5.344

7.  Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis.

Authors:  Ivan I Kirov; Songtao Liu; Roman Fleysher; Lazar Fleysher; James S Babb; Joseph Herbert; Oded Gonen
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

8.  Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica.

Authors:  C S Yu; F C Lin; K C Li; T Z Jiang; C Z Zhu; W Qin; H Sun; P Chan
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

9.  Early anisotropy changes in the corpus callosum of patients with optic neuritis.

Authors:  M Bester; C Heesen; S Schippling; R Martin; X-Q Ding; B Holst; J Fiehler
Journal:  Neuroradiology       Date:  2008-05-06       Impact factor: 2.804

10.  Benign and secondary progressive multiple sclerosis: a preliminary quantitative MRI study.

Authors:  M Filippi; G J Barker; M A Horsfield; P R Sacares; D G MacManus; A J Thompson; P S Tofts; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.